United States
Germany
Japan
United Kingdom
China
TNFRSF8 mouse monoclonal antibody, clone OTI18D3 (formerly 18D3)
| Applications | FC, IHC, WB |
| Reactivities | Human |
Antibodies
PPM1B mouse monoclonal antibody, clone OTI3C9 (formerly 3C9)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse, Rat |
RPA2 mouse monoclonal antibody, clone OTI7C12 (formerly 7C12)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat, Dog |
TP53 mouse monoclonal antibody, clone OTI2F7 (formerly 2F7)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
LSM1 mouse monoclonal antibody, clone OTI9D7 (formerly 9D7)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse, Rat |
UNG mouse monoclonal antibody, clone OTI1F8 (formerly 1F8)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Anti-SSB mouse monoclonal antibody, clone OTI1E11 (formerly 1E11)
| Applications | FC, IF, IP, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
TNFRSF8 mouse monoclonal antibody, clone OTI18D3 (formerly 18D3)
| Applications | FC, IHC, WB |
| Reactivities | Human |
活动过滤器
clear Category
- Antibodies
优化搜索结果
Target Symbol
Reactivities
Antibody Hosts
Knockout (KO) Validation
Assay Types
Brands
Pathways
- MAPK signaling pathway (12)
- Base excision repair (10)
- Cell cycle (10)
- Chronic myeloid leukemia (9)
- Huntington's disease (9)
- Pathways in cancer (9)
- Amyotrophic lateral sclerosis (ALS) (6)
- Apoptosis (6)
- Basal cell carcinoma (6)
- Bladder cancer (6)
- Colorectal cancer (6)
- Cytokine-cytokine receptor interaction (6)
- Endometrial cancer (6)
- Glioma (6)
- Melanoma (6)
- Neurotrophin signaling pathway (6)
- Non-small cell lung cancer (6)
- Pancreatic cancer (6)
- Prostate cancer (6)
- Small cell lung cancer (6)
- Systemic lupus erythematosus (6)
- Thyroid cancer (6)
- Wnt signaling pathway (6)
- p53 signaling pathway (6)
- DNA replication (4)
- Mismatch repair (4)
- Nucleotide excision repair (4)
- Homologous recombination (3)
- Notch signaling pathway (3)
- Primary immunodeficiency (3)
- RNA degradation (3)
- Regulation of actin cytoskeleton (3)
